Robbins Geller Gets $60M In $400M Pfizer Class Action Deal
A New York federal judge awarded $60 million in attorneys' fees Tuesday to Robbins Geller Rudman & Dowd LLP, lead counsel in a shareholder class action accusing Pfizer Inc. of misleading...To view the full article, register now.
Already a subscriber? Click here to view full article